Kangmei Pharmaceutical Co., Ltd. (600518.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 26.41B |
| Enterprise Value | 25.51B |
| P/E Ratio | 212.9 |
| PEG Ratio | -0.21 |
| Price/Sales Ratio | 3.79 |
| Price/Book Ratio | 2.47 |
| Enterprise/Revenue | 3.53 |
| Enterprise/EBITDA | 86.87 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | -0.05 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.01 |
Income Statement
| Revenue | 5.24B |
| Revenue/Share | 0.35 |
| Gross Profit | 839.72M |
| EBITDA | 395.6M |
| Net Income | 10.33M |
| Diluted EPS | 0 |
Balance Sheet
| Total Cash | 1.36B |
| Total Cash/Share | 0.1 |
| Total Debt | 124.49M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 1.35 |
| Book Value Per Share | 0.54 |
Price History
| 52-Week Change | -36.84 |
| 52-Week High | 2.16 |
| 52-Week Low | 1.16 |
| Moving Average 50 Days | 1.33 |
| Moving Average 200 Days | 1.53 |
Statistics
| Average Volume | 149.06M |
| Shares Outstanding | 13.83B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | June 16, 2015 |
AD
